Technical Analysis for DXR - Daxor Corporation

Grade Last Price % Change Price Change
grade A 14.5 -2.68% -0.40
DXR closed down 2.68 percent on Friday, January 18, 2019, on 17 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Very Strong Up Up Up
See historical DXR trend table...

Date Alert Name Type % Chg
Jan 18 Bearish Engulfing Bearish 0.00%
Jan 18 NR7 Range Contraction 0.00%
Jan 18 Inside Day Range Contraction 0.00%
Jan 18 Wide Bands Range Expansion 0.00%
Jan 18 Overbought Stochastic Strength 0.00%
Jan 17 Wide Bands Range Expansion -2.68%
Jan 17 Overbought Stochastic Strength -2.68%
Jan 16 Wide Bands Range Expansion 0.00%
Jan 16 Overbought Stochastic Strength 0.00%
Jan 15 New 52 Week Closing High Bullish -2.75%

Older signals for DXR ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
Daxor Corporation, a medical device manufacturing company, offers biotech services in the United States. The company develops and markets BVA-100 Blood Volume Analyzer, an instrument that measures human blood volume. BVA-100 Blood Volume Analyzer is used to diagnose and treat patients with heart failure, kidney failure, hypertension, and syncope; aid in fluid and blood transfusion management in the critical care unit; and aid in the diagnosis and treatment of disorders of red blood cell volume, including polycythemia and anemia, as well as used in pre-surgical evaluation of red blood cell volume. The company also provides cryobanking services, including blood and semen storage and related services. Daxor Corporation markets its products to hospitals and radiology imaging centers. The company was formerly known as Idant Corporation and changed its name to Daxor Corporation in May 1973. Daxor Corporation was founded in 1970 and is headquartered in New York, New York.
Is DXR a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 4 bullish, 0 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 21.66
52 Week Low 3.4
Average Volume 85,797
200-Day Moving Average 6.7863
50-Day Moving Average 8.4456
20-Day Moving Average 11.014
10-Day Moving Average 13.167
Average True Range 1.2821
ADX 52.28
+DI 32.8347
-DI 6.3624
Chandelier Exit (Long, 3 ATRs ) 11.6037
Chandelier Exit (Short, 3 ATRs ) 10.3963
Upper Bollinger Band 16.1897
Lower Bollinger Band 5.8383
Percent B (%b) 0.84
BandWidth 93.98402
MACD Line 1.9552
MACD Signal Line 1.5851
MACD Histogram 0.3701
Fundamentals Value
Market Cap 54.96 Million
Num Shares 3.79 Million
EPS -0.21
Price-to-Earnings (P/E) Ratio -69.05
Price-to-Sales 30.32
Price-to-Book 1.11
PEG Ratio 0.00
Dividend 0.03
Dividend Yield 0.21%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 15.67
Resistance 3 (R3) 15.75 15.43 15.48
Resistance 2 (R2) 15.43 15.14 15.40 15.41
Resistance 1 (R1) 14.97 14.95 14.81 14.89 15.34
Pivot Point 14.65 14.65 14.58 14.62 14.65
Support 1 (S1) 14.19 14.36 14.03 14.11 13.66
Support 2 (S2) 13.87 14.17 13.84 13.59
Support 3 (S3) 13.41 13.87 13.53
Support 4 (S4) 13.33